Literature DB >> 14718458

Bronchoscope reprocessing and infection prevention and control: bronchoscopy-specific guidelines are needed.

Arjun Srinivasan1, Linda L Wolfenden, Xiaoyan Song, Trish M Perl, Edward F Haponik.   

Abstract

BACKGROUND: It has been recommended that bronchoscopists familiarize themselves with national recommendations for bronchoscope reprocessing practices, but the extent of guideline awareness is unclear.
METHODS: We distributed a survey to practicing bronchoscopists at two meetings. Questions addressed infection control issues related to bronchoscopy and specific reprocessing recommendations.
RESULTS: A total of 46 surveys were completed by medical directors of bronchoscopy suites (26%) and attending bronchoscopists (74%) who had graduated from medical school a median of 22 years ago and performed a median of 19 procedures per month. Sixty-five percent of respondents, including 55% of directors, were not familiar with national reprocessing recommendations, and 39% did not know the approach to reprocessing at their own institution. Respondents who did > 20 procedures per month trended toward being more likely to be aware of guidelines (54% vs 26%, p = 0.09) and were less likely to answer "do not know" to more than one question about specific reprocessing details (25% vs 70%, p = 0.003). Seventy-eight percent of respondents did not know local practices for at least one of the reprocessing details. Forty-six percent of respondents stated their institutions followed recommendations that records be kept of the specific bronchoscope used in each case.
CONCLUSIONS: Many experienced bronchoscopists are unfamiliar with national guidelines and local practices related to bronchoscope reprocessing. Publication of bronchoscope-specific, comprehensive reprocessing guidelines in the pulmonary literature may help increase familiarity with this crucial process.

Entities:  

Mesh:

Year:  2004        PMID: 14718458     DOI: 10.1378/chest.125.1.307

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  2 in total

1.  Pentraxin 3 (PTX-3) Levels in Bronchoalveolar Lavage Fluid as a Lung Cancer Biomarker.

Authors:  Tinghua Hu; LiBang Qiao; Hong Li; Hui Ren; Qian Ning; Hong Zhou; Xue Chen; Zhongmin Sun; Liangrong Shen
Journal:  Dis Markers       Date:  2020-06-10       Impact factor: 3.434

Review 2.  American College of Chest Physicians and American Association for Bronchology [corrected] consensus statement: prevention of flexible bronchoscopy-associated infection.

Authors:  Atul C Mehta; Udaya B S Prakash; Robert Garland; Edward Haponik; Leonard Moses; William Schaffner; Gerard Silvestri
Journal:  Chest       Date:  2005-09       Impact factor: 9.410

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.